Insys Therapeutics (INSY) COO Terminated
- Wall Street dips on Trump protectionism, Qualcomm drag
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- After-Hours Stock Movers 1/23: (REXX) (MRCY) (SYNC) Higher; (FSM) (OCUL) (CASC) Lower (more...)
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Insys Therapeutics (NASDAQ: INSY) said Dan Brennan, the former Executive Vice President and Chief Operating Officer of Insys Therapeutics, Inc., was terminated.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chemical Financial (CHFC) Names Jeffrey Tate to Board of Directors
- iPath S&P 500 VIX ST Futures ETN (VXX) up 1.55%
- Banc of California (BANC) Appoints Robert Sznewajs to Chairman of the Board
Create E-mail Alert Related CategoriesHot Mgmt Changes, Management Changes, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!